Connection

Co-Authors

This is a "connection" page, showing publications co-authored by HUAMIN WANG and CRAIG LOGSDON.
Connection Strength

1.251
  1. Cell surface lactate receptor GPR81 is crucial for cancer cell survival. Cancer Res. 2014 Sep 15; 74(18):5301-10.
    View in: PubMed
    Score: 0.121
  2. The CUL7/F-box and WD repeat domain containing 8 (CUL7/Fbxw8) ubiquitin ligase promotes degradation of hematopoietic progenitor kinase 1. J Biol Chem. 2014 Feb 14; 289(7):4009-17.
    View in: PubMed
    Score: 0.117
  3. Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression. J Hematol Oncol. 2012 Apr 04; 5:15.
    View in: PubMed
    Score: 0.104
  4. An NF-?B pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice. J Clin Invest. 2012 Apr; 122(4):1519-28.
    View in: PubMed
    Score: 0.104
  5. Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models. Gut. 2012 Sep; 61(9):1315-22.
    View in: PubMed
    Score: 0.101
  6. Trefoil factor 1 stimulates both pancreatic cancer and stellate cells and increases metastasis. Pancreas. 2011 Aug; 40(6):815-22.
    View in: PubMed
    Score: 0.099
  7. Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma. Cancer. 2011 Feb 15; 117(4):734-43.
    View in: PubMed
    Score: 0.094
  8. Ras activity levels control the development of pancreatic diseases. Gastroenterology. 2009 Sep; 137(3):1072-82, 1082.e1-6.
    View in: PubMed
    Score: 0.086
  9. Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer. Cancer Res. 2009 Feb 01; 69(3):1063-70.
    View in: PubMed
    Score: 0.083
  10. Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. Cancer Res. 2008 Oct 01; 68(19):7811-8.
    View in: PubMed
    Score: 0.082
  11. Bisphosphonates inhibit stellate cell activity and enhance antitumor effects of nanoparticle albumin-bound paclitaxel in pancreatic ductal adenocarcinoma. Mol Cancer Ther. 2014 Nov; 13(11):2583-94.
    View in: PubMed
    Score: 0.031
  12. A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice. Gastroenterology. 2013 Dec; 145(6):1449-58.
    View in: PubMed
    Score: 0.029
  13. A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth. EMBO Mol Med. 2013 Sep; 5(9):1322-34.
    View in: PubMed
    Score: 0.028
  14. Pancreatic cancer-associated Cathepsin E as a drug activator. J Control Release. 2013 May 10; 167(3):221-7.
    View in: PubMed
    Score: 0.028
  15. Activation of nuclear factor-?B in acinar cells increases the severity of pancreatitis in mice. Gastroenterology. 2013 Jan; 144(1):202-10.
    View in: PubMed
    Score: 0.027
  16. Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding Ras and activating Ras signaling. PLoS One. 2012; 7(8):e42699.
    View in: PubMed
    Score: 0.027
  17. Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma. Clin Cancer Res. 2011 Nov 15; 17(22):7015-23.
    View in: PubMed
    Score: 0.025
  18. Molecular profiling of direct xenograft tumors established from human pancreatic adenocarcinoma after neoadjuvant therapy. Ann Surg Oncol. 2012 Jul; 19 Suppl 3:S395-403.
    View in: PubMed
    Score: 0.025
  19. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res. 2009 Jul 15; 69(14):5820-8.
    View in: PubMed
    Score: 0.022
  20. Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer. Cancer Res. 2008 Aug 01; 68(15):6100-8.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.